Histiocytic sarcoma localised in the thyroid—a case report

por De Vos, Filip Y. F. L., Gerding, Martin N., Arends, Jan W., Wegman, Jurgen J.
Publicado 2008

Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review

por IJzerman-Korevaar, Margriet, Snijders, Tom J., de Graeff, Alexander, Teunissen, Saskia C. C. M., de Vos, Filip Y. F.
Publicado 2018

Perfusion imaging with arterial spin labeling (ASL)–MRI predicts malignant progression in low‑grade (WHO grade II) gliomas

por Flies, Christina M., Snijders, Tom J., Van Seeters, Tom, Smits, Marion, De Vos, Filip Y. F., Hendrikse, Jeroen, Dankbaar, Jan Willem
Publicado 2021

Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis

por Senders, Joeky T., Goldhaber, Nicole H., Cote, David J., Muskens, Ivo S., Dawood, Hassan Y., De Vos, Filip Y. F. L., Gormley, William B., Smith, Timothy R., Broekman, Marike L. D.
Publicado 2017

Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas

por van de Geer, Wesley S, Hoogstrate, Youri, Draaisma, Kaspar, Robe, Pierre A, Bins, Sander, Mathijssen, Ron H J, French, Pim, van de Werken, Harmen J G, de Vos, Filip Y F
Publicado 2021

Comparison of 2-Hydroxyglutarate Detection With sLASER and MEGA-sLASER at 7T

por Shams, Zahra, van der Kemp, Wybe J. M., Emir, Uzay, Dankbaar, Jan Willem, Snijders, Tom J., de Vos, Filip Y. F., Klomp, Dennis W. J., Wijnen, Jannie P., Wiegers, Evita C.
Publicado 2021

Cognitive impairments are independently associated with shorter survival in diffuse glioma patients

por van Kessel, Emma, Huenges Wajer, Irene M. C., Ruis, Carla, Seute, Tatjana, Fonville, Susanne, De Vos, Filip Y. F. L., Verhoeff, Joost J. C., Robe, Pierre A., van Zandvoort, Martine J. E., Snijders, Tom J.
Publicado 2020

Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma

por van Kessel, Emma, Schuit, Ewoud, Huenges Wajer, Irene M. C., Ruis, Carla, De Vos, Filip Y. F. L., Verhoeff, Joost J. C., Seute, Tatjana, van Zandvoort, Martine J. E., Robe, Pierre A., Snijders, Tom J.
Publicado 2021

Conventional MRI Criteria to Differentiate Progressive Disease From Treatment-Induced Effects in High-Grade (WHO Grade 3–4) Gliomas

por Flies, Christina M., van Leuken, Karlijn H., ten Voorde, Marlies, Verhoeff, Joost J.C., De Vos, Filip Y.F., Seute, Tatjana, Robe, Pierre A., Witkamp, Theodoor D., Hendrikse, Jeroen, Dankbaar, Jan Willem, Snijders, Tom J.
Publicado 2022

A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignanci...

por Cirkel, Geert A., Kerklaan, Bojana Milojkovic, Vanhoutte, Frédéric, der Aa, Annegret Van, Lorenzon, Giocondo, Namour, Florence, Pujuguet, Philippe, Darquenne, Sophie, de Vos, Filip Y. F., Snijders, Tom J., Voest, Emile E., Schellens, Jan H. M., Lolkema, Martijn P.
Publicado 2016

Complications, compliance, and undertreatment do not explain the relationship between cognition and survival in diffuse glioma patients

por van Kessel, Emma, Krijnen, Eva A, IJpelaar, Suzanne, Huenges Wajer, Irene M C, Ruis, Carla, Seute, Tatjana, De Vos, Filip Y F L, Verhoeff, Joost J C, Robe, Pierre A, van Zandvoort, Martine J E, Snijders, Tom J
Publicado 2022

Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520

por Verheijen, Remy B., van der Biessen, Diane A. J., Hotte, Sebastien J., Siu, Lillian L., Spreafico, Anna, de Jonge, Maja J. A., Pronk, Linda C., De Vos, Filip Y. F. L., Schnell, David, Hirte, Hal W., Steeghs, Neeltje, Lolkema, Martijn P.
Publicado 2019

Characteristics of patients with advanced cancer preferring not to know prognosis: a multicenter survey study

por van der Velden, Naomi C. A., van Laarhoven, Hanneke W. M., Burgers, Sjaak A., Hendriks, Lizza E. L., de Vos, Filip Y. F. L., Dingemans, Anne-Marie C., Jansen, Joost, van Haarst, Jan-Maarten W., Dits, Joyce, Smets, Ellen MA, Henselmans, Inge
Publicado 2022

Prevalence and Predictors of Physician-Patient Discordance in Prognostic Perceptions in Advanced Cancer

por van der Velden, Naomi Cornelia Anna, Han, Paul K J, van Laarhoven, Hanneke W M, de Vos, Filip Y F L, Hendriks, Lizza E L, Burgers, Sjaak A, Dingemans, Anne-Marie C, van Haarst, Jan Maarten W, Dits, Joyce, Smets, Ellen M A, Henselmans, Inge
Publicado 2023

Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies

por de Jonge, Maja J. A., Steeghs, Neeltje, Lolkema, Martijn P., Hotte, Sebastien J., Hirte, Hal W., van der Biessen, Diane A. J., Abdul Razak, Albiruni R., De Vos, Filip Y. F. L., Verheijen, Remy B., Schnell, David, Pronk, Linda C., Jansen, Monique, Siu, Lillian L.
Publicado 2019

Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial

por Henselmans, Inge, van Laarhoven, Hanneke W.M., van Maarschalkerweerd, Pomme, de Haes, Hanneke C.J.M., Dijkgraaf, Marcel G.W., Sommeijer, Dirkje W., Ottevanger, Petronella B., Fiebrich, Helle‐Brit, Dohmen, Serge, Creemers, Geert‐Jan, de Vos, Filip Y.F.L., Smets, Ellen M.A.
Publicado 2019

Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma

por Schuler, Martin, Zimmer, Lisa, Kim, Kevin B., Sosman, Jeffrey A., Ascierto, Paolo A., Postow, Michael A., De Vos, Filip Y.F.L., van Herpen, Carla M.L., Carlino, Matteo S., Johnson, Douglas B., Berking, Carola, Reddy, Micaela B., Harney, Allison S., Berlin, Jordan D., Amaria, Rodabe N.
Publicado 2022

Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study

por Lassman, Andrew B., Sepúlveda-Sánchez, Juan Manuel, Cloughesy, Timothy F., Gil-Gil, Miguel J., Puduvalli, Vinay K., Raizer, Jeffrey J., De Vos, Filip Y.F., Wen, Patrick Y., Butowski, Nicholas A., Clement, Paul M.J., Groves, Morris D., Belda-Iniesta, Cristóbal, Giglio, Pierre, Soifer, Harris S., Rowsey, Steven, Xu, Cindy, Avogadri, Francesca, Wei, Ge, Moran, Susan, Roth, Patrick
Publicado 2022

Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cance...

por van Geel, Robin M. J. M., van Brummelen, Emilie M. J., Eskens, Ferry A. L. M., Huijberts, Sanne C. F. A., de Vos, Filip Y. F. L., Lolkema, Martijn P. J. K., Devriese, Lot A., Opdam, Frans L., Marchetti, Serena, Steeghs, Neeltje, Monkhorst, Kim, Thijssen, Bas, Rosing, Hilde, Huitema, Alwin D. R., Beijnen, Jos H., Bernards, René, Schellens, Jan H. M.
Publicado 2020

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

por Subbiah, Vivek, Kreitman, Robert J., Wainberg, Zev A., Gazzah, Anas, Lassen, Ulrik, Stein, Alexander, Wen, Patrick Y., Dietrich, Sascha, de Jonge, Maja J. A., Blay, Jean-Yves, Italiano, Antoine, Yonemori, Kan, Cho, Daniel C., de Vos, Filip Y. F. L., Moreau, Philippe, Fernandez, Elena Elez, Schellens, Jan H. M., Zielinski, Christoph C., Redhu, Suman, Boran, Aislyn, Passos, Vanessa Q., Ilankumaran, Palanichamy, Bang, Yung-Jue
Publicado 2023